Literature DB >> 26160399

Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices.

Moritz Seiffert1, Buntaro Fujita2, Maxim Avanesov3, Clemens Lunau4, Gerhard Schön5, Lenard Conradi6, Emir Prashovikj2, Smita Scholtz7, Jochen Börgermann2, Werner Scholtz7, Ulrich Schäfer4, Gunnar Lund3, Stephan Ensminger2, Hendrik Treede6.   

Abstract

AIMS: Calcification of the device landing zone is linked to paravalvular regurgitation after transcatheter aortic valve implantation (TAVI). The mechanisms remain incompletely understood and the performance of next-generation transcatheter heart valves (THV) has not been investigated. We evaluated the impact of calcification patterns on residual aortic regurgitation (AR) after TAVI with different THV in patients with severe aortic stenosis. METHODS AND
RESULTS: TAVI was performed in 537 patients at two centres. Devices implanted were the Edwards Sapien XT (n = 254), Medtronic CoreValve (n = 123), JenaValve (n = 62), Medtronic Engager (n = 56), and Symetis Acurate (n = 42) prostheses. Calcification of the device landing zone was retrospectively assessed from contrast-enhanced multidetector computed tomography data and correlated with echocardiographic and clinical data. Calcium volumes of the aortic valve and left-ventricular outflow tract were associated with residual AR: No AR, 604 mm(3) (inter-quartile range, IQR 349-916); trace AR, 639 mm(3) (IQR 368-948); mild AR, 710 mm(3) (IQR 412-2078); ≥moderate AR, 1041 mm(3) (IQR 791-1417, P = 0.001). Device landing zone calcium, particularly if located in the left-ventricular outflow tract, and a low cover index were predictive of AR. Differences in the incidence of AR were observed with regard to THV type. Higher calcium volume was associated with the need for post-dilation (n = 134, median 852 [IQR 342-945] vs. 604 [IQR 542-1207] mm(3), P < 0.001).
CONCLUSION: Calcification of the device landing zone, particularly if located inferior to the annulus, was independently associated with residual AR after TAVI with all evaluated THV; however, the incidence of paravalvular leakage differed significantly between the devices implanted. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  TAVI; aortic regurgitation; calcification; device landing zone; transcatheter heart valve

Mesh:

Substances:

Year:  2015        PMID: 26160399     DOI: 10.1093/ehjci/jev174

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  19 in total

1.  Outcomes with a latest generation self-expandable, intra-annular, re-sheathable transcatheter heart valve system: analysis of patients with impaired left ventricular function and determinants for pacemaker implantation.

Authors:  Andreas Schaefer; Niklas Neumann; Matthias Linder; Niklas Schofer; Yvonne Schneeberger; Florian Deuschl; Gerhard Schoen; Stefan Blankenberg; Hermann Reichenspurner; Lenard Conradi; Ulrich Schäfer
Journal:  Clin Res Cardiol       Date:  2018-04-28       Impact factor: 5.460

2.  Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification.

Authors:  Won-Keun Kim; Johannes Blumenstein; Christoph Liebetrau; Andreas Rolf; Luise Gaede; Arnaud Van Linden; Mani Arsalan; Mirko Doss; Jan G P Tijssen; Christian W Hamm; Thomas Walther; Helge Möllmann
Journal:  Clin Res Cardiol       Date:  2017-08-09       Impact factor: 5.460

3.  Impact of valvular resistance on aortic regurgitation after transcatheter aortic valve replacement according to the type of prosthesis.

Authors:  Masahiko Asami; Thomas Pilgrim; Stefan Stortecky; Dik Heg; Eva Roost; Stephan Windecker; Lukas Hunziker
Journal:  Clin Res Cardiol       Date:  2019-03-30       Impact factor: 5.460

4.  Predilatation Prior to Transcatheter Aortic Valve Implantation: Is it Still a Prerequisite?

Authors:  Matteo Pagnesi; Luca Baldetti; Paolo Del Sole; Antonio Mangieri; Marco B Ancona; Damiano Regazzoli; Nicola Buzzatti; Francesco Giannini; Antonio Colombo; Azeem Latib
Journal:  Interv Cardiol       Date:  2017-09

Review 5.  The Role of Multimodality Imaging in Transcatheter Aortic Valve Replacement.

Authors:  Qi Liu; Rebecca T Hahn
Journal:  Curr Cardiol Rep       Date:  2019-07-19       Impact factor: 2.931

6.  Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device.

Authors:  Victor Mauri; Florian Deuschl; Thomas Frohn; Niklas Schofer; Matthias Linder; Elmar Kuhn; Andreas Schaefer; Volker Rudolph; Navid Madershahian; Lenard Conradi; Tanja K Rudolph; Ulrich Schäfer
Journal:  Clin Res Cardiol       Date:  2018-04-17       Impact factor: 5.460

7.  Incremental Value of Aortomitral Continuity Calcification for Risk Assessment after Transcatheter Aortic Valve Replacement.

Authors:  Martin J Willemink; Eva Maret; Kegan J Moneghetti; Juyong Brian Kim; Francois Haddad; Yukari Kobayashi; Takeshi Nishi; Koen Nieman; Nicholas Cauwenberghs; Tatiana Kuznetsova; Kai Higashigaito; Anna M Sailer; Alan C Yeung; Anson M Lee; D Craig Miller; Michael Fischbein; William F Fearon; Dominik Fleischmann
Journal:  Radiol Cardiothorac Imaging       Date:  2019-12-19

Review 8.  Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations.

Authors:  Saima Siddique; Hemal Gada; Mubashir A Mumtaz; Amit N Vora
Journal:  Curr Cardiol Rep       Date:  2019-11-28       Impact factor: 2.931

9.  Early commercial experience with a newly designed balloon-expandable transcatheter heart valve: 30-day outcomes and implications of preprocedural computed tomography.

Authors:  Andreas Schaefer; Fabienne Plassmeier; Niklas Schofer; Lukas Vogel; Sebastian Ludwig; Yvonne Schneeberger; Matthias Linder; Till Demal; Moritz Seiffert; Stefan Blankenberg; Hermann Reichenspurner; Dirk Westermann; Lenard Conradi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-08

10.  New insights on potential permanent pacemaker predictors in TAVR using the largest self-expandable device.

Authors:  Verena Veulemans; Derk Frank; Hatim Seoudy; Steffen Wundram; Kerstin Piayda; Oliver Maier; Christian Jung; Amin Polzin; Norbert Frey; Malte Kelm; Tobias Zeus
Journal:  Cardiovasc Diagn Ther       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.